“Bimekizumab Versus Ustekinumab in Plaque Psoriasis: Lasting Efficacy Translates to Rapid and Sustained Improvements in Quality of Life in the BE VIVID Multicenter, Randomized, Double-Blinded Phase 3 Trial”. 2021. SKIN The Journal of Cutaneous Medicine 5 (1): s17. https://doi.org/10.25251/skin.5.supp.17.